Veeva Systems

UCB and Veeva Collaborate to Advance the Patient Experience in Clinical Trials

Retrieved on: 
Tuesday, May 23, 2023
Heart, Partnership, Clinical trial, Trial of the century, UCB, Patient, NYSE, Pharmaceutical industry, Medical imaging, Veeva Systems

BRUSSELS and PLEASANTON, Calif., May 23, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) and UCB, a global biopharmaceutical company, today announced a collaboration that will focus on technology-driven solutions aimed at improving the patient experience and trial efficiency. The collaboration will see UCB adopt Veeva ePRO and Veeva eConsent, to provide a patient-centric, digital experience to study participants and actively influence the strategic direction of these and other applications based on learnings. Together, Veeva and UCB aim to set a new industry standard for digital clinical trials with multiple applications that meet the unique needs of patients.

Key Points: 
  • Together, Veeva and UCB aim to set a new industry standard for digital clinical trials with multiple applications that meet the unique needs of patients.
  • "The partnership between UCB and Veeva presents a significant opportunity to drive progress in clinical study execution," said Iris Loew-Friedrich, executive vice president and chief medical officer at UCB.
  • Veeva ePRO and Veeva eConsent are part of Veeva Vault Clinical Suite , a set of integrated capabilities that simplify the technology landscape of clinical trials for both clinical operations and clinical data management.
  • "We're excited to partner with UCB to advance patient-centric digital trials," said Veeva CEO Peter Gassner.

New Veeva Link MedTech Provides Real-Time Data to Optimize Scientific Engagement

Retrieved on: 
Thursday, May 18, 2023
Veeva Systems, Automation, NYSE, Medtech, Medical device

PLEASANTON, Calif. , May 18, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Link MedTech, a data application developed for medtech companies to identify scientific experts, personalize engagement, and map activities across the healthcare ecosystem. Built on the same platform as Veeva Link Key People, Link MedTech combines automation and human curation for an accurate, in-depth view of expert profiles in medical devices and diagnostics globally.

Key Points: 
  • Real-time intelligence on key experts helps drive timely, relevant engagement
    PLEASANTON, Calif. , May 18, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Link MedTech , a data application developed for medtech companies to identify scientific experts, personalize engagement, and map activities across the healthcare ecosystem.
  • Built on the same platform as Veeva Link Key People , Link MedTech combines automation and human curation for an accurate, in-depth view of expert profiles in medical devices and diagnostics globally.
  • Link MedTech equips medical affairs and commercial teams with real-time data to effectively engage with customers and key opinion leaders (KOLs).
  • Learn how companies can lead more relevant scientific engagement with experts leveraging Link MedTech at Veeva MedTech Summit , May 30 to June 1 in Chicago.

New Veeva Link MedTech Provides Real-Time Data to Optimize Scientific Engagement

Retrieved on: 
Thursday, May 18, 2023
Veeva Systems, NYSE, Medtech, Automation, Medical device

BARCELONA, Spain, May 18, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Link MedTech, a data application developed for medtech companies to identify scientific experts, personalize engagement, and map activities across the healthcare ecosystem. Built on the same platform as Veeva Link Key People, Link MedTech combines automation and human curation for an accurate, in-depth view of expert profiles in medical devices and diagnostics globally.

Key Points: 
  • Real-time intelligence on key experts helps drive timely, relevant engagement
    BARCELONA, Spain, May 18, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva Link MedTech , a data application developed for medtech companies to identify scientific experts, personalize engagement, and map activities across the healthcare ecosystem.
  • Built on the same platform as Veeva Link Key People , Link MedTech combines automation and human curation for an accurate, in-depth view of expert profiles in medical devices and diagnostics globally.
  • Link MedTech equips medical affairs and commercial teams with real-time data to effectively engage with customers and key opinion leaders (KOLs).
  • Learn how companies can lead more relevant scientific engagement with experts leveraging Link MedTech at Veeva MedTech Summit , 30 May to 1 June in Chicago.

PM360 Announces Winners of The Ninth Annual ELITE 100 Awards

Retrieved on: 
Tuesday, May 16, 2023
Nexium, Data science, Marketing, GoodRx, EVP, Hospira, Associate, Cardinal Health, Patient, McCourt, HR, Disease, Eli Lilly and Company, Constipation, Attention, Snow, Diagnosis, Entrepreneurship, Growth, Digital marketing, Immunology, FAAN, Engagement, Organon, Caregiver, PR, Ironwood Pharmaceuticals, Exception, COVID-19, IBS-C, Health, ELITE, Boehringer Ingelheim, Abdominal pain, Sustainability, ImmunoGen, RN, Bloating, CO, Providers, Glaucoma, Lead, Mirati Therapeutics, Regulatory science, AstraZeneca, HCP, Gastroesophageal reflux disease, Veeva Systems, Novartis, Omeprazole, Management, Pharmaceutical industry, Beauty salon, Generic drug, Esomeprazole, GERD

NEW YORK, May 16, 2023 /PRNewswire/ -- PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, today announced the winners of its 9th Annual ELITE 100. The ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people and teams in the healthcare and life sciences industries based on their career accomplishments. Out of more than 500 submissions, 100 winners are selected by the PM360 editorial staff across various categories that span every facet of the industry.

Key Points: 
  • NEW YORK, May 16, 2023 /PRNewswire/ -- PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, today announced the winners of its 9th Annual ELITE 100.
  • Out of more than 500 submissions, 100 winners are selected by the PM360 editorial staff across various categories that span every facet of the industry.
  • PM360 also selects one person as the "Uber ELITE," or the individual among the nominees who best personifies the criteria of a PM360 ELITE.
  • McCourt will serve as the keynote speaker at the annual ELITE 100 Awards Event to celebrate this year's winners.

Biopharmas Boost Marketing Effectiveness by 23% by Synchronizing Digital Media with Field Engagement

Retrieved on: 
Tuesday, May 16, 2023
DTC, Veeva Systems, Software, NYSE, Marketing, CRM, HCP, Behavior, Sales

PLEASANTON, Calif., May 16, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today released the latest Veeva 2023 Trends in HCP Omnichannel Engagement Report. Findings show synchronizing digital marketing with biopharma field engagement with healthcare professionals (HCPs) increases marketing effectiveness by 23%. The report uncovers there is a large opportunity to improve impact as only 27% of HCPs engaged with the field also see digital advertising within a three-month timeframe.

Key Points: 
  • Findings show synchronizing digital marketing with biopharma field engagement with healthcare professionals (HCPs) increases marketing effectiveness by 23%.
  • Aggregated media measurement and health data from Veeva Crossix and field activity from Veeva CRM , the report reveals:
    Combining marketing and sales activities within three months drives greater impact.
  • Brands whose field teams engaged HCPs within three months of digital advertising increased marketing effectiveness by 23%.
  • More than 70% of brand interaction with HCPs is unsynchronized, providing opportunities to increase effectiveness with timely coordination of field engagements and digital advertising.

Veeva Partners with Sanofi to Transform its Quality System

Retrieved on: 
Wednesday, May 10, 2023
CHC, GxP, NYSE, Locksmithing, Management, Sanofi, Veeva Systems

PLEASANTON, Calif., May 10, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Sanofi is implementing Veeva Vault QMS and Veeva Vault QualityDocs to modernize quality management across the company, including consumer healthcare (CHC). As the first key milestone of Sanofi's implementation, the CHC division is now live with Vault QualityDocs and the first business processes of Vault QMS. To streamline content management and GxP training, the CHC division also selected Veeva Vault Training. The rest of Sanofi will go live over the coming year.

Key Points: 
  • PLEASANTON, Calif., May 10, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Sanofi is implementing Veeva Vault QMS and Veeva Vault QualityDocs to modernize quality management across the company, including consumer healthcare (CHC).
  • With Veeva Vault Quality Suite , Sanofi will standardize quality management across all divisions and sites on a modern cloud platform.
  • "We're excited to partner with Sanofi on their quality transformation journey," said Mike Jovanis, vice president, quality and manufacturing at Veeva.
  • As the shift to digital quality gains momentum, more than 500 life sciences companies use Vault Quality applications to modernize quality management across R&D and manufacturing.

Veeva Partners with Sanofi to Transform its Quality System

Retrieved on: 
Wednesday, May 10, 2023
CHC, GxP, NYSE, Locksmithing, Management, Sanofi, Veeva Systems

BARCELONA, Spain, May 10, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Sanofi is implementing Veeva Vault QMS and Veeva Vault QualityDocs to modernize quality management across the company, including consumer healthcare (CHC). As the first key milestone of Sanofi's implementation, the CHC division is now live with Vault QualityDocs and the first business processes of Vault QMS. To streamline content management and GxP training, the CHC division also selected Veeva Vault Training. The rest of Sanofi will go live over the coming year.

Key Points: 
  • BARCELONA, Spain, May 10, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Sanofi is implementing Veeva Vault QMS and Veeva Vault QualityDocs to modernize quality management across the company, including consumer healthcare (CHC).
  • With Veeva Vault Quality Suite , Sanofi will standardize quality management across all divisions and sites on a modern cloud platform.
  • "We're excited to partner with Sanofi on their quality transformation journey," said Mike Jovanis, vice president, quality and manufacturing at Veeva.
  • As the shift to digital quality gains momentum, more than 500 life sciences companies use Vault Quality applications to modernize quality management across R&D and manufacturing.

Veeva to Release Fiscal 2024 First Quarter Results on May 31, 2023

Retrieved on: 
Wednesday, May 3, 2023
Veeva Systems, NYSE, Communications satellite, Cryptocurrency

PLEASANTON, Calif., May 3, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its first quarter, which ended April 30, 2023, after market close on May 31, 2023.

Key Points: 
  • PLEASANTON, Calif., May 3, 2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its first quarter, which ended April 30, 2023, after market close on May 31, 2023.
  • Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m.
  • Veeva will post prepared remarks to its investor relations website at https://ir.veeva.com approximately at 1:05 p.m. PT (4:05 p.m.
  • ET).

COGNIZANT REPORTS FIRST QUARTER 2023 RESULTS

Retrieved on: 
Wednesday, May 3, 2023
Cloud, FCCI, Workforce, Telecom, Guy-wire, Cognizant, Amazon Web Services, Medicaid, Nextgen, Travel, Partnership, Agility, Share repurchase, Department for Environment, Food and Rural Affairs, Telecommunications, Health care, DSB, Food, Microsoft, Jetstar, Government, Boehringer Ingelheim, Investment, City, Growth, Nike, Environment, Horizon, AWS, Veeva Systems, Cryptocurrency, Video game

The Company repurchased 3.2 million shares for $200 million during the first quarter under its share repurchase program.

Key Points: 
  • The Company repurchased 3.2 million shares for $200 million during the first quarter under its share repurchase program.
  • As of March 31, 2023, there was $2.6 billion remaining under the share repurchase authorization.
  • In May 2023, the Company declared a quarterly cash dividend of $0.29 per share, a 7% increase year-over-year, for shareholders of record on May 19, 2023.
  • Cognizant will host a conference call on May 3, 2023, at 5:00 p.m. (Eastern) to discuss the Company's first quarter 2023 results.

Veeva Introduces Link Workflow, a No-Code Platform for Building Custom Workflow Applications

Retrieved on: 
Wednesday, May 3, 2023
Cloud, Service, Veeva Systems, CRM, NYSE, Software

PLEASANTON, Calif., May 3, 2023 /PRNewswire/ -- 2023 Veeva Commercial Summit, North America — Veeva Systems (NYSE: VEEV) today announced the availability of Veeva Link Workflow, a no-code platform to build custom workflow applications on Veeva Link real-time data.

Key Points: 
  • PLEASANTON, Calif., May 3, 2023 /PRNewswire/ -- 2023 Veeva Commercial Summit, North America — Veeva Systems (NYSE: VEEV) today announced the availability of Veeva Link Workflow , a no-code platform to build custom workflow applications on Veeva Link real-time data.
  • "Many critical processes in life sciences live outside of established application boundaries and are managed in spreadsheets and email," said Kilian Weiss, general manager of Veeva Link.
  • Veeva Link is a family of connected data applications for real-time intelligence that includes Link Key People, Link Key Accounts, Link Scientific Awareness, Link Medical Insights, Link SiteBase, and Link TrialBase.
  • Customers can build custom workflows on Link data using the Link Workflow no-code platform.